Director Paul Stuka buys 20,000 InspireMD (NSPR) shares in open-market trade
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
InspireMD director Paul Stuka reported an open-market purchase of 20,000 shares of InspireMD, Inc. common stock on May 27, 2026 at $0.875 per share. Following this transaction, he directly holds 667,871 shares. Separately, 423,704 shares are held indirectly through Osiris Investment Partners, L.P., with no new transaction reported for those indirectly held shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,000 shares ($17,500)
Net Buy
2 txns
Insider
Stuka Paul
Role
null
Bought
20,000 shs ($18K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 20,000 | $0.875 | $18K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 667,871 shares (Direct, null);
Common Stock — 423,704 shares (Indirect, See Footnote)
Footnotes (1)
- The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $0.87 to $0.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Key Figures
Shares purchased: 20,000 shares
Purchase price: $0.875 per share
Direct holdings after transaction: 667,871 shares
+2 more
5 metrics
Shares purchased
20,000 shares
Open-market purchase on May 27, 2026
Purchase price
$0.875 per share
Weighted average price, range $0.87–$0.88
Direct holdings after transaction
667,871 shares
Common stock directly owned by Paul Stuka
Indirectly held shares
423,704 shares
Held by Osiris Investment Partners, L.P.
Net buy shares
20,000 shares
Net buy direction in transaction summary
Key Terms
open-market purchase, weighted average price, beneficially own, pecuniary interest, +1 more
5 terms
open-market purchase financial
"Purchase in open market or private transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially own financial
"the Reporting Person may be deemed to beneficially own the reported securities."
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
pecuniary interest financial
"disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein"
Section 16 regulatory
"shall not be deemed an admission of beneficial ownership for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
What did InspireMD (NSPR) director Paul Stuka report in this Form 4?
Director Paul Stuka reported buying 20,000 shares of InspireMD common stock in an open-market transaction. The purchase occurred on May 27, 2026 at $0.875 per share, increasing his directly owned position to 667,871 shares after the transaction.
What does the weighted average price range mean in the InspireMD (NSPR) Form 4?
The weighted average price of $0.875 reflects multiple trades executed between $0.87 and $0.88 per share. The filing notes Stuka will provide detailed trade breakdowns, including the number of shares at each price, upon request to investors or regulators.